Avonex, used to treat certain types of multiple sclerosis, can cause side effects ranging from mild, such as headaches and muscle pain, to serious, including depression and liver damage. Long-term ...

CAMBRIDGE, MA – Sept. 11, 2009 – Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

AVONEX(R) (interferon beta-1a), the most prescribed multiple sclerosis (MS) treatment worldwide, adhered to treatment more than patients taking other approved disease-modifying therapies (DMTs) ...

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Biogen Idec Canada Inc today announced AVONEX ® PEN ™ is now available for patients with relapsing multiple sclerosis (MS) and patients with a single ...

CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Biogen Idec’s multiple sclerosis drug Avonex can cause severe liver damage, U.S. regulatory officials and the company warned Wednesday, the latest in a series of blows to MS patients. Subscribe to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Biogen Idec (Nasdaq: BIIB), a biotechnology company best ...

Avonex (interferon beta-1a) may not be safe to use while pregnant or breastfeeding. Certain factors may determine whether you should use the drug during this time. »Learn more about Avonex, including ...

OBJECTIVE: To determine levels of serum interferon beta (IFNbeta) neutralizing antibody (NAb) and neopterin-an IFN biologic response marker-in patients with MS treated with Betaseron or Avonex.

June 16 (Reuters) - A drug approved to prevent rejection of transplanted kidneys significantly reduced relapses of multiple sclerosis in a late stage-trial sponsored by Biogen Idec and AbbVie Inc, but ...